Completed PHASE4 INTERVENTIONAL 1-arm NCT00067938

Bipolar Study in Adults at Least 18 Years of Age

Lamictal for Use in Treatment of Bipolar Disorder In Adults. A Practical Clinical Assessment of Tolerability and Clinical Effectiveness.

Sponsor: GlaxoSmithKline

Conditions Bipolar Disorder

Interventions lamotrigine

Updated 7 times since 2017 Last updated: Aug 31, 2016 Started: Aug 31, 2003 Primary completion: Aug 31, 2004 Completion: Aug 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Bipolar Disorder and is currently completed. GlaxoSmithKline leads this study, which shows 7 recorded versions since 2003 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Aug 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline

Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adrian, United States , Albany, United States , Albertville, United States , Albuquerque, United States , Altamonte Springs, United States , Alton, United States , Amityville, United States , Annapolis, United States , Anniston, United States , Arlington, United States and 243 more locations